Trending
- Patient cell drug profiling identifies p53-linked vulnerabilities in refractory lymphoid malignancies
- OTUD6A promotes de novo pyrimidine synthesis by deubiquitinating and stabilizing CAD in cervical cancer
- Atezolizumab Plus Chemotherapy Improves PFS in dMMR/MSI-H Metastatic CRC
- FDA Advisory Committee Backs RP1/Nivolumab for Advanced Melanoma
- CAR T-Cell Therapy Could Soon Expand Into Non-Oncology Indications
- TKTL1 mediates metabolic adaptation and stress resistance in pancreatic cancer cells under nutrient-deprived conditions
- Capricor’s data clash with the FDA| STAT
- Cevostamab Shows Durable Responses in Relapsed/Refractory Multiple Myeloma
Friday, July 31